The North America Inhaled Nitric Oxide Market would witness market growth of 6.1% CAGR during the forecast period (2020-2026). This nitric oxide can be inhaled via the nose or mouth, which helps in relaxing the smooth muscles to broaden all the blood vessels in the oxygenated regions of the lungs. It is mostly utilized together with the ventilator and other components to cure pulmonary hypertension in newborn babies and adults with respiratory problems.
It is clinically proven that nitric oxide gas is effective in enlarging blood vessels to ease down the muscle tension that takes in oxygen more efficiently in the body. Moreover, nitric oxide is mostly utilized in breathing systems like ventilators. The inhaled nitric oxide is regarded as a strong & selective pulmonary vasodilator, which does not reduce systemic vascular tone.
It is considered that INO therapy was effective to enhance oxygenation in newborn babies with persistent pulmonary hypertension of the newborn (PPHN). It is due to its selective pulmonary vasodilator effects, inhaled nitric oxide therapy is a crucial treatment for term newborns with hypoxemic respiratory problems because of PPHN. In 1999, the Food and Drug Administration of the U.S. had first approved Inhaled Nitric Oxide for its usage as a medical gas to cure hypoxic respiratory failure related to the clinical or echocardiographic confirmation of pulmonary hypertension in term and late preterm infants. Afterward, inhaled nitric oxide therapy is clinically used to cure PPHN in term and late preterm infants without consensus.
Based on Application, the market is segmented into Neonatal Respiratory Treatment, Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS) and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The Neonatal Respiratory Treatment market dominated the Canada Inhaled Nitric Oxide Market by Application in 2019, growing at a CAGR of 6 % during the forecast period. The Chronic Obstructive Pulmonary Disease (COPD) market is expected to witness a CAGR of 7.1% during (2020 - 2026).
Free Valuable Insights: Inhaled Nitric Oxide Market in North America is expected to register a CAGR of 6.1% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Getinge AB, Merck Group, Halma PLC, Linde PLC (Praxair, Inc.), Air Liquide S.A., Beyond Air, Inc., Mallinckrodt PLC (International Minerals and Chemical Corporation), VERO Biotech LLC, Nu-Med Plus, Inc. and Novoteris, LLC.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Neonatal Respiratory Treatment
- Chronic Obstructive Pulmonary Disease (COPD)
- Acute Respiratory Distress Syndrome (ARDS)
- Other Applications
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Getinge AB
- Merck Group
- Halma PLC
- Linde PLC (Praxair, Inc.)
- Air Liquide S.A.
- Beyond Air, Inc.
- Mallinckrodt PLC (International Minerals and Chemical Corporation)
- VERO Biotech LLC
- Nu-Med Plus, Inc.
- Novoteris, LLC
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Inhaled Nitric Oxide Market, by Application
1.4.2 North America Inhaled Nitric Oxide Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Inhaled Nitric Oxide Market – Global
Chapter 4. North America Inhaled Nitric Oxide Market by Application
4.1 North America Neonatal Respiratory Treatment Repellent Market by Country
4.2 North America Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country
4.3 North America Acute Respiratory Distress Syndrome (ARDS) Market by Country
4.4 North America Other Applications Market by Country
Chapter 5. North America Inhaled Nitric Oxide Market by Country
5.1 USA Inhaled Nitric Oxide Market
5.1.1 USA Inhaled Nitric Oxide Market by Application
5.2 Canada Inhaled Nitric Oxide Market
5.2.1 Canada Inhaled Nitric Oxide Market by Application
5.3 Mexico Inhaled Nitric Oxide Market
5.3.1 Mexico Inhaled Nitric Oxide Market by Application
5.4 Rest of North America Inhaled Nitric Oxide Market
5.4.1 Rest of North America Inhaled Nitric Oxide Market by Application
Chapter 6. Company Profiles
6.1 Getinge AB
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional Analysis
6.1.4 Research & Development Expense
6.2 Merck Group
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Halma PLC
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Linde PLC (Praxair, Inc.)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Acquisition and Mergers:
6.5 Air Liquide S.A.
6.5.1 Company Overview
6.5.1 Financial Analysis
6.6 Beyond Air, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Research & Development Expense
6.6.4 Recent strategies and developments:
6.6.4.1 Trials and Approvals:
6.7 Mallinckrodt PLC (International Minerals and Chemical Corporation)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Trials and Approvals:
6.7.5.2 Partnerships, Collaborations, and Agreements:
6.8 VERO Biotech LLC
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Trials and Approvals:
6.9 Nu-Med Plus, Inc.
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. Novoteris, LLC
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Trials and Approvals:
TABLE 1 North America Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 2 North America Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 3 North America Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 4 North America Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 5 North America Neonatal Respiratory Treatment Repellent Market by Country, 2016 - 2019, USD Million
TABLE 6 North America Neonatal Respiratory Treatment Repellent Market by Country, 2020 - 2026, USD Million
TABLE 7 North America Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2016 - 2019, USD Million
TABLE 8 North America Chronic Obstructive Pulmonary Disease (COPD) Repellent Market by Country, 2020 - 2026, USD Million
TABLE 9 North America Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2016 - 2019, USD Million
TABLE 10 North America Acute Respiratory Distress Syndrome (ARDS) Market by Country, 2020 - 2026, USD Million
TABLE 11 North America Other Applications Market by Country, 2016 - 2019, USD Million
TABLE 12 North America Other Applications Market by Country, 2020 - 2026, USD Million
TABLE 13 North America Inhaled Nitric Oxide Market by Country, 2016 - 2019, USD Million
TABLE 14 North America Inhaled Nitric Oxide Market by Country, 2020 - 2026, USD Million
TABLE 15 USA Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 16 USA Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 17 USA Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 18 USA Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 19 Canada Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 20 Canada Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 21 Canada Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 22 Canada Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 23 Mexico Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 24 Mexico Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 25 Mexico Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 26 Mexico Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 27 Rest of North America Inhaled Nitric Oxide Market, 2016 - 2019, USD Million
TABLE 28 Rest of North America Inhaled Nitric Oxide Market, 2020 - 2026, USD Million
TABLE 29 Rest of North America Inhaled Nitric Oxide Market by Application, 2016 - 2019, USD Million
TABLE 30 Rest of North America Inhaled Nitric Oxide Market by Application, 2020 - 2026, USD Million
TABLE 31 Key Information – Getinge AB
TABLE 32 key Information – Merck Group
TABLE 33 key Information – Halma PLC
TABLE 34 key Information – Linde PLC
TABLE 35 Key information – Air Liquide S.A.
TABLE 36 Key information – Beyond Air, Inc.
TABLE 37 Key information – Mallinckrodt PLC
TABLE 38 Key Information – VERO Biotech LLC
TABLE 39 key Information – Nu-Med Plus, Inc.
TABLE 40 key Information –Novoteris, LLC
List of Figures
FIG 1 Methodology for the research